相关实验视频
Updated: May 23, 2025

08:58
Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
15.8K
通过DRD2介导的AMPK化调节肝硬化发生的情况
1School of Life Science and Technology, China Pharmaceutical University, Nanjing, Jiangsu, China.
概括
多巴胺D2受体 (DRD2) 内部化通过破坏AKT-AMPK信号,使脂肪肝疾病 (MASH) 恶化. 一种DRD2抗剂,L-741626,通过阻断这种途径,显示出治疗MASH的潜力.
科学领域:
- 代谢障碍 代谢障碍 代谢障碍
- 肝病学 肝病学是一种肝病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 包括D2多巴胺受体 (DRD2) 在内的G蛋白结合受体 (GPCR) 是代谢障碍的潜在药物标.
- DRD2在调节肝脂代谢中的特定作用及其在MASH中的参与在很大程度上仍未被阐明.
研究的目的:
- 调查DRD2在MASH病变发生中的作用.
- 阐明DRD2影响肝脂代谢的分子机制.
- 评估MASH中DRD2抗剂的治疗潜力.
主要方法:
- 通过使用高脂肪,高胆固醇/甲胺胆缺乏 (HFHC/MCD) 饮食,建立了MASH的小鼠模型.
- 基相关病毒血清型2/8 (AAV2/8) 载体被用于肝脏特异性敲击和DRD2的过度表达.
- 分子技术包括共免疫沉,西式涂抹,免疫光和免疫组织化学被用来探索机制和选对手.
主要成果:
- 在高脂肪条件下,PKC激活促进DRD2内部化,加剧MASH.
- 抑制DRD2改善了MASH的进展,而DRD2的过度表达加剧了MASH的进展.
- 通过β-arrestin2和pAKT的DRD2内部化,去酸化pAKT (T308),导致AMPK降解和增加脂肪酸.
- DRD2抗剂L-741626抑制了DRD2内部化,并通过调节AKT-AMPK信号轴在治疗MASH方面表现出有效性.
结论:
- 在高脂肪环境中DRD2内部化驱动MASH通过AKT-AMPK信号通路的进展.
- DRD2抗剂L-741626为MASH提供了一个有前途的治疗策略.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
cAMP-dependent Protein Kinase Pathways
6.1K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.1K
Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
The Unfolded Protein Response
4.4K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
4.4K
GPCR Desensitization
5.7K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
5.7K
MAPK Signaling Cascades
5.1K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.1K

